EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
Price:
11.08 USD
-0.72%
Updated:
May 28, 2024
EyePoint Pharmaceuticals Inc
Other Non-Cash Items
|
EyePoint Pharmaceuticals Inc
Other Non-Cash Items Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Other Non-Cash Items Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
|
Other Non-Cash Items
$22.6m
|
CAGR 3-Years
43%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
33%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Non-Cash Items
-$18.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Non-Cash Items
$13.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
74%
|
|
|
Pfizer Inc
NYSE:PFE
|
Other Non-Cash Items
$5.6B
|
CAGR 3-Years
63%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Other Non-Cash Items
$12.9B
|
CAGR 3-Years
23%
|
CAGR 5-Years
48%
|
CAGR 10-Years
31%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Non-Cash Items
$3B
|
CAGR 3-Years
373%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
31%
|
See Also
What is EyePoint Pharmaceuticals Inc's Other Non-Cash Items?
Other Non-Cash Items
22.6m
USD
22.6m
USD
Based on the financial report for Mar 31, 2024, EyePoint Pharmaceuticals Inc's Other Non-Cash Items amounts to 22.6m USD.
What is EyePoint Pharmaceuticals Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 10Y
33%
33%
Over the last year, the Other Non-Cash Items growth was -36%. The average annual Other Non-Cash Items growth rates for EyePoint Pharmaceuticals Inc have been 43% over the past three years , -6% over the past five years , and 33% over the past ten years .
You don't have any saved screeners yet
